Gene Query: PHAX

Dataset Description Geneva Score
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 16.26
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 16.19
RIG-I and MDA5 fRIP during KSHV lytic reactivation 15.88
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 14.24
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 13.86
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 12.39
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 12.26
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 12.01
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 11.71
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 11.21
Expression by CD133+ cells isolated from the adult human exocrine pancreas 11.01
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 11.0
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 10.31
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 10.29
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 10.1
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 10.05
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 9.91
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 9.82
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 9.71
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 9.63
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 9.59
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 9.59
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 9.43
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 9.38
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 9.23
Gene expression in PANC1 cells treated with Rakicidin 9.22
Human embryonic stem cells in E8 and AKIT culture medium 9.15
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 9.15
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 9.11
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 9.11
Transcriptomic analyssis following EHMT1/2 inhibition 9.09
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 9.09
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 9.08
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 8.93
MYCL and EP400 are required for Max and MCPyV mediated gene activation 8.74
mRNA expression profile of Lymphocytes 8.74
scRNASeq analysis of cycling cardiomyocytes 8.73
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 8.69
DART-seq: an antibody-free method for global m6A detection 8.63
Transcriptional profiles of normal human mature B cells 8.62
Ribosomal footprinting of CN34-Parental and CN34-LM1a 8.62
8.23
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.21
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 8.06
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 8.03
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 7.97
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 7.97
HNF1A deficiency impairs β-cell fate, granule maturation and function 7.88
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 7.86
Differentially expressed genes post knock down of lincDUSP26 7.83
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 7.81
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 7.61
Comprehensive comparative analysis of 5’ end RNA sequencing methods 7.56
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.38
R430: A potent inbibitor of DNA and RNA viruses 7.29
SLIGRL-induced gene expression changes in NHEK cells 7.28
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 7.23
Genome wide miR-191 target profile determined by RIP and gene expression profiling 7.23
Seletive inhibition of CDK9 in DLBCL cell lines 7.17
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 7.15
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 7.1
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 7.03
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 6.96
The evolution of N6-methyladenosine in primates 6.94
Ribosomal footprinting of MDA-Parental and MDA-LM2 6.91
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 6.86
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 6.86
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.84
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 6.8
ETV7 and interferon response 6.79
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 6.79
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 6.77
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 6.77
Effect of drugs on transcriptomic profiles 6.76
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 6.75
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 6.71
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 6.7
Cajal bodies are linked to genome conformation [RNA-Seq] 6.7
Cajal bodies are linked to genome conformation 6.7
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 6.65
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 6.63
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 6.6
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 6.58
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 6.57
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 6.53
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 6.48
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 6.31
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 6.28
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.22
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.22
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 6.21
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 6.19
Splicing and epigenetic factors jointly regulate epidermal differentiation 6.16
TCF7L1 knockdown in pancreatic cancer 6.07
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 6.06
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 6.03
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 6.03
Global Mapping of Human RNA-RNA Interactions 6.01
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 5.9
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 5.83
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 5.83
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 5.81
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 5.81
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 5.81
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 5.8
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 5.74
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.64
Neonatal and adult human testis defined at the single-cell level 5.64
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.61
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.61
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 5.58
Mitochondrial dsRNA triggers antiviral signalling in humans 5.55
Novel Targeting of Transcription and Metabolism in Glioblastoma 5.52
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 5.51
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 5.44
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 5.33
CD86 regulates a pro-survival signal in myeloma cells 5.32
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 5.32
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 5.31
Effect of Hotair overexpression in human breast cancer cell lines 5.29
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 5.28
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 5.28
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 5.28
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 5.25
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.24
Genome wide expression change by RNF168 knocking down in NEC cells 5.22
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 5.22
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 5.21
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 5.21
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 5.17
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 5.17
Generating Patterned Kidney Organoids for Studying Development and Diseases 5.1
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 5.06
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 5.04
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 5.0
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 4.95
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 4.92
Tracking of dCas9-methyltransferase footprints 4.87
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 4.87
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 4.85
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 4.85
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 4.85
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 4.85
Human neutrophil genome during PMA- and E. coli encounter-induced activation 4.85
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 4.84
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 4.84
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 4.83
Integrating single-cell transcriptomic data across different conditions, technologies, and species 4.81
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 4.78
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 4.78
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 4.77
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 4.74
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 4.74
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 4.72
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 4.72
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.72
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.69
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 4.69
Capturing the Interactome of Newly Transcribed RNA 4.68
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.68
Unique features and clinical importance of acute alloreactive immune responses 4.67
Global analysis of alternative splicing regulated by RBM10 4.67
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 4.67
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 4.66
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 4.66
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 4.65
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.61
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.61
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 4.6
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 4.57
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 4.56
RNAseq Study in CC-671 Treated Cal-51 Cells 4.55
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 4.53
A Unique Epigenomic Landscape Defines Human Erythropoiesis 4.53
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 4.52
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 4.52
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 4.5
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 4.5
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 4.45
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 4.44
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 4.44
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 4.43
Identification of Nrf2 regulated genes by RNA sequencing 4.42
Nrf2 regulated genes in A549 cells 4.42
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.42
CROP-Seq in Primary Human T Cells 4.37
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 4.37
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 4.36
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 4.36
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 4.36
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 4.35
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 4.35
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 4.35
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.34
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 4.32
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 4.32
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 4.32
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 4.31
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 4.31
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 4.3
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 4.3
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.29
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.29
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 4.29
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 4.29
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 4.29
RNAseq Analysis in glioblastoma cells treated with Mepazine 4.28
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 4.27
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 4.25
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 4.24
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 4.23
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 4.2
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 4.18
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 4.17
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 4.17
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.16
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 4.13
RNA-seq analysis of uveal melanoma cells treated with FR900359 4.13
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 4.08
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 4.03
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 4.03
mRNA recovered upon RNF219 IP. [RNA-IP] 4.03
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.03
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 4.01
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.99
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 3.96
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 3.95
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 3.87
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 3.87
Human cell line and subcutaneous tumor 3.79
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.78
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 3.77
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 3.74
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 3.72
Effect of PBK knockdown on C4-2 cell transcriptome 3.7
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 3.7
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 3.68
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 3.68
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 3.62
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.61
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 3.56
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 3.51
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 3.51
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 3.5
Identification of renal resident macrophages across species 3.5
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 3.48
DRB/GRO-Seq -/+ UV 3.47
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 3.47
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 3.47
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 3.46
RNA sequencing of primary human platelets and in vitro cell lines 3.45
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 3.44
Gene expression profiling of human and murine in vitro muscle differentiation 3.42
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 3.41
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 3.38
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 3.38
Transcriptomic analysis of human tonsillar TFH subsets 3.38
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.36
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 3.35
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 3.34
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 3.33
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 3.33
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 3.3
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.28
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 3.19
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 3.16
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 3.13
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 3.11
CD73 knockdown effect in pancreatic cancer cell lines 3.08
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.06
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.06
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 3.04
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 2.96
Transcriptomic profile of human embryonic renal corpuscles 2.94
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 2.91
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 2.89
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 2.89
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 2.88
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 2.87
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 2.84
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 2.84
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 2.83
Differential gene expression of human melanoma cells [RNA-seq] 2.81
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 2.81
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.78
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.78
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 2.77
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 2.77
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 2.76
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.74
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 2.73
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 2.7
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.69
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.65
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.65
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 2.62
IRF1 regulates IFN dependent and independent gene expression 2.61
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 2.61
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 2.61
MCF-7 as a model for functional analysis of breast cancer risk variants 2.58
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.57
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 2.53
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 2.53
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 2.53
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 2.5
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 2.5
Ribosomal protein RPL26 is the principal target of UFMylation 2.5
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.5
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 2.47
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 2.47
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 2.46
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.46
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.42
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.4
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.37
Analysis of transcriptional regulation by Myt1 and Myt1l 2.37
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 2.32
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 2.31
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 2.29
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.29
Effect of from Human Umbilical Vein Endothelial Cells 2.28
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 2.26
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.23
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.23
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 2.21
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 2.21
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 2.21
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 2.2
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 2.18
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.17
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.14
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.14
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 2.12
Gene expression profile in breast cancer cells 2.12
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.12
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 2.06
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 2.06
p53 activity results in DNA replication fork processivity 2.04
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 2.03
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 2.02
6mer seed toxicity in tumour suppressive microRNAs 1.99
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.95
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.95
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.94
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.93
Real-time observation of light-controlled transcription in living cells 1.93
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.93
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.91
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.91
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.88
4sU-seq of HFF exposed to salt and heat stress 1.87
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.84
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.82
The Genetic Landscape of Diamond-Blackfan Anemia 1.7
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 1.69
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.68
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 1.6
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.56
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.56
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.56
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.54
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.53
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.53
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.47
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.47
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.46
RNA sequencing of mechanically strained NHEKs and control NHEKs 1.46
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.44
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 1.42
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.39
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.38
Determining mRNA half-lives on a transcriptome-wide scale 1.38
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.36
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.36
EWS-Fli and LNC regulated genes in comparison to GFP samples 1.36
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 1.29
The MEF2B Regulatory Network 1.29
The MEF2B Regulatory Network - RNA-seq data 1.29
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.29
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.28
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.28
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 1.28
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.26
Transcriptome-wide modulation of splicing by the exon junction complex 1.26
Cleavage Factor Im as a key regulator of 3’ UTR length 1.25
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.24
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.22
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 1.22
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 1.22
RNA-seq analysis of control and Myc-induced U2OS cells 1.22
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.2
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.19
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.19
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.19
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.18
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 1.16
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 1.16
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.15
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 1.13
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.09
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.09
siRNA-mediated knockdown 1.08
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 1.08
HBEC-shp53-PCHD7 1.06
Role of cervicovaginal microbiota in genital inflammation 1.05
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.04
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.03
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.02
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 1.0
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 0.99
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.98
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.98
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 0.98
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.97
MARS Seq data from human cortical organoids 0.96
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 0.95
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.95
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.94
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 0.94
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.92
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.92
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.9
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.9
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.89
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.88
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.88
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.87
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.87
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 0.85
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.83
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.82
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 0.8
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.75
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.72
Genome-wide analysis of the Integrator complex (HTS) 0.69
Genome-wide analysis of the Integrator complex 0.69
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.63
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.61
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.61
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.58
Function and hormonal regulation of GATA3 in human first trimester placentation 0.57
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.56
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 0.56
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.55
RNA-seq data 0.55
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.53
Primary Human B-cell Temporal Response to CD40L Stimulation 0.53
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 0.53
Effect of BMP inhibition or stimulation of primary human keratinocytes 0.53
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.53
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.52
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.5
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.49
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.47
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.47
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.46
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.45
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.44
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.43
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.43
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.43
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.41
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.4
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.4
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.4
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.38
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.36
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.34
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.34
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.31
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.31
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.31
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.3
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.3
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.3
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.3
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.26
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.24
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.24
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.23
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.22
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.22
Modulation of nonsense-mediated decay by rapamycin 0.2
Interphase condensins regulate ligand-depedent enhancer activation 0.19
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.19
HNRNPM-regulated splicing dependencies in prostate cancer 0.18
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.18
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.17
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.17
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.16
m6A-dependent regulation of messenger RNA stability 0.15
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.11
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.1
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 0.1
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.05
EGR1-controlled transcriptome of T HESCs 0.03
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.03
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.02
Identification of a LIF-responsive replication-competent human β cell 0.01
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation